Home » Topics » BioWorld Science, Cardiovascular

BioWorld Science, Cardiovascular
RSS

Long QT genes mostly short on evidence

Feb. 3, 2020

PULSAR trial of sotatercept in pulmonary arterial hypertension meets primary endpoint

Jan. 28, 2020

Retinoic X receptor as therapeutic target for poststroke recovery

Jan. 28, 2020

Novel panaxatriol derivative shows efficacy in rat model of MI/R injury

Jan. 27, 2020

Fat or fiber, cFAP activation is problematic for heart

Jan. 27, 2020

FDA approves Ozempic to reduce MACE in adults with type 2 diabetes and heart disease

Jan. 17, 2020

HDAC blockade seen to restore cardiopulmonary function in felines

Jan. 16, 2020

Cynata receives approval for its U.K. phase II study in critical limb ischemia

Jan. 15, 2020

Targeting SMPD1 ameliorates leptin resistance-derived endothelial dysfunction in rats

Jan. 15, 2020

New cardiac sarcomere inhibitors discovered at Cytokinetics

Jan. 14, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...